STRATA Skin Sciences (NASDAQ:SSKN) Posts Quarterly Earnings Results

STRATA Skin Sciences (NASDAQ:SSKNGet Free Report) announced its quarterly earnings data on Wednesday. The medical device company reported ($0.10) EPS for the quarter, reports. STRATA Skin Sciences had a negative net margin of 34.92% and a negative return on equity of 65.76%. The firm had revenue of $6.75 million during the quarter.

STRATA Skin Sciences Stock Performance

NASDAQ:SSKN opened at $0.39 on Friday. STRATA Skin Sciences has a 52 week low of $0.26 and a 52 week high of $1.08. The firm has a 50-day moving average price of $0.46 and a two-hundred day moving average price of $0.50. The company has a current ratio of 1.05, a quick ratio of 1.06 and a debt-to-equity ratio of 1.60.

STRATA Skin Sciences’s stock is scheduled to reverse split before the market opens on Friday, June 7th. The 1-10 reverse split was announced on Friday, June 7th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, June 7th.

Hedge Funds Weigh In On STRATA Skin Sciences

Several hedge funds have recently bought and sold shares of SSKN. Azzad Asset Management Inc. ADV grew its position in shares of STRATA Skin Sciences by 289.5% during the 1st quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock valued at $25,000 after purchasing an additional 49,800 shares in the last quarter. Chicago Partners Investment Group LLC raised its stake in STRATA Skin Sciences by 162.0% in the fourth quarter. Chicago Partners Investment Group LLC now owns 64,223 shares of the medical device company’s stock valued at $33,000 after purchasing an additional 39,706 shares in the last quarter. Finally, 22NW LP increased its holdings in shares of STRATA Skin Sciences by 56.1% in the 3rd quarter. 22NW LP now owns 5,369,954 shares of the medical device company’s stock worth $3,195,000 after buying an additional 1,930,693 shares during the last quarter. Hedge funds and other institutional investors own 32.43% of the company’s stock.

About STRATA Skin Sciences

(Get Free Report)

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.

Featured Stories

Earnings History for STRATA Skin Sciences (NASDAQ:SSKN)

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.